CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-10 | HIGGINS JOHN L Director | Sale | −992 | $380.15 | $377K | 6,014 |
| 2022-06-08 | HIGGINS JOHN L Director | Sale | −600 | $366.09 | $220K | 4,606 |
| 2022-06-07 | HIGGINS JOHN L Director | Sale | −1,000 | $364.31 | $364K | 4,606 |
| 2022-06-07 | Kummeth Charles R. CHIEF EXECUTIVE OFFICER | Sale | −5,104 | $365.00 | $1.9M | 198,338 |
| 2021-11-19 | Kelderman Kim Pres. Diagnostics & Genom | Sale | −100 | $503.76 | $50K | 400 |
| 2021-11-19 | Kelderman Kim Pres. Diagnostics & Genom | Sale | −400 | $505.78 | $202K | 0 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −700 | $504.09 | $353K | 27,777 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −200 | $504.78 | $101K | 27,577 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −300 | $502.99 | $151K | 27,277 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −537 | $504.14 | $271K | 26,740 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −400 | $505.01 | $202K | 26,340 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −4,054 | $502.77 | $2.0M | 22,286 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −9,043 | $503.61 | $4.6M | 13,243 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −8,989 | $504.39 | $4.5M | 4,254 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −2,535 | $505.49 | $1.3M | 1,719 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −401 | $506.24 | $203K | 1,318 |
| 2021-11-02 | Hippel James Chief Financial Officer | Sale | −200 | $525.10 | $105K | 10,755 |
| 2021-11-01 | Hippel James Chief Financial Officer | Sale | −3,566 | $525.61 | $1.9M | 16,011 |
| 2021-11-01 | Hippel James Chief Financial Officer | Sale | −2,880 | $526.50 | $1.5M | 13,131 |
| 2021-11-01 | Hippel James Chief Financial Officer | Sale | −1,433 | $527.50 | $756K | 11,698 |
Page 2 of 17 · 325 trades